Clinical experiences with administration of oral antidiabetic agent Buformin
Sieberová, R.
Casopis Lekaru Ceskych 110(18): 420-421
1971
ISSN/ISBN: 0008-7335 PMID: 5574346 Document Number: 42157
Document emailed within 1 workday
Related Documents
Uglesic, A.; Ljahnicky, N. 1975: Experiences with the oral antidiabetic agent, Glurenorm, in diabetics with kidney diseases Medizinische Monatsschrift 29(9): 408-411D'Onofrio, F.; Pempinello, R.; Romis, L. 1972: Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide Arzneimittel-Forschung 22(11): 1879-1881
Leubner, H. 1973: Results of a clinical test on the oral antidiabetic agent glibornuride (Ro 6-4563) Wiener Medizinische Wochenschrift 123(17): 277-282
Behpour, A. 1980: Diabetes in adults and old age. Treatment with an oral antidiabetic agent Zfa. Zeitschrift für Allgemeinmedizin 56(22): 1412-1414
El Allaf, D.; D'Orio, V.; Cremers, S.; Carlier, J. 1984: Acute clinical benefits of a new inotropic agent AR-L 115 BS after I.v. and oral administration Giornale Italiano di Cardiologia 14(10): 830-834
Schmitt, E.W.; Nijssen, J. 1978: Glibornuride--field study on an oral antidiabetic agent. Results of therapy with gluboride in a large number of patients Die Medizinische Welt 29(29-30): 1170-1174
Perrin, L.F. 1971: Clinical study of a new bronchodilator agent active in oral administration: Eupneron Sedativ Lyon Medical 225(12): 1287-1288
Voss, D.; Fuchs, G.; Schneider, D.; Schneider, J. 1972: Effect of the oral antidiabetic agent glibornuride on blood coagulation, blood platelets, and fibrinolysis Arzneimittel-Forschung 22(Suppl 12a): 2219
Dhirawani, M.K.; Patel, J.C.; Kabadi, U.M. 1970: A clinical trial with glycodiazine--a new oral antidiabetic compound Indian Journal of Medical Sciences 24(2): 53-62
Jansen, W. 1972: Experiences with oral administration of Megagrisevit in old age. 2 Zeitschrift für Allgemeinmedizin 48(8): 386-387
Sekido, S.; Ninomiya, K.; Araki, T.; Ueno, M.; Kinbara, M. 1984: Experimental studies on oral administration of nitrosourea anti-tumor agent, MCNU Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(7): 1492-1500
Carcassi, A. 1973: Clinical experiences with a new non-steroid antirheumatic agent Minerva Medica 64(45): 2361-2364
Maeshiba, Y.; Kiyota, Y.; Yamashita, K.; Yoshimura, Y.; Motohashi, M.; Tanayama, S. 1997: Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys Arzneimittel-Forschung 47(1): 29-35
Nishioka, B.; Ouchi, T.; Watanabe, S.; Umehara, M.; Yamane, E.; Yahata, K.; Muto, F.; Kojima, O.; Nomiyama, S.; Sakita, M.; Fujita, Y.; Majima, S. 1982: Follow-up study of preoperative oral administration of an antineoplastic agent as an adjuvant chemotherapy in stomach cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(8): 1427-1432
Grujić, M.; Rizvanbegović, B.; Perinović, M.; Perinović, I.D. 1976: Glurenorm a new peroral antidiabetic agent belonging to the group of sulfonylurea compounds Medicinski Arhiv 30(2): 119-121
Ferrari, M.; Bigi, N. 1970: Clinical experiences with a new anti-arrhythmic agent: disopyramide (Rhythmodan) Minerva Medica 61(71): 3728-3733
Weber, H. 1971: Clinical experiences with a new spasmoanalgesic agent in double-blind test Zeitschrift für Allgemeinmedizin 47(6): 299-300
Neviani, V.; Tosi, P.; Prampolini, M.L. 1976: 1st experiences with the clinical use of a new beta-blocking agent (tolamolol) in some heart diseases La Clinica Terapeutica 77(5): 451-458
Giudice, G.; Cardona, S.; Serra, G.C. 1973: Preliminary clinical experiences with a non-depolarizing curarizing agent with steroid structure: pancuronium bromide Minerva Anestesiologica 39(10): 433-442
Brandt, S. 2013: The clinical effects of zinc as a topical or oral agent on the clinical response and pathophysiologic mechanisms of acne: a systematic review of the literature Journal of Drugs in Dermatology: Jdd 12(5): 542-545